Starting this year, China’s National Health Commission (NHC) will conduct an annual evaluation of medical treatment services for women in critical conditions during pregnancy and the perinatal period. The evaluation aims to guide local health institutions in enhancing their treatment systems, improving their capabilities to handle urgent and severe conditions, and ensuring the safety of both mothers and infants. In 2022, China reported a maternal death rate of 15.7 per 100,000, a 2.5% decrease from the previous year, and an infant mortality rate of 4.9 per 1,000. The NHC plans to complete the first round of evaluation by September, with the goal of establishing an evaluation mechanism for the medical treatment system and technology for critical pregnant women by 2027.
Source – CGTN